Mangoceuticals (MGRX) Non-Current Debt (2022)
Mangoceuticals (MGRX) reported Non-Current Debt of $78260.0 for Q4 2022.
Mangoceuticals (MGRX) Non-Current Debt (2022) Analysis & Trends
Mangoceuticals (MGRX) has 1 years of Non-Current Debt data on file, last reported at $78260.0 in Q4 2022.
- For the quarter ending Q4 2022, Non-Current Debt changed N/A year-over-year to $78260.0; the trailing twelve-month figure through Dec 2022 stood at $78260.0 (changed N/A YoY), and the FY2022 full-year result was $78260.0, changed N/A from the prior year.
- Non-Current Debt held at $78260.0 in Q4 2022.
- In the past five years, Non-Current Debt ranged from a high of $78260.0 in Q4 2022 to a low of $78260.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 31.81 Bn | 24.49 Bn | 662.02 Mn | - |
| 2 | BrightSpring Health Services | 14.76 Bn | 13.86 Bn | 482.22 Mn | 2.44 Bn |
| 3 | Healthequity | 8.36 Bn | 8.10 Bn | 256.31 Mn | 942.66 Mn |
| 4 | Hinge Health | 5.91 Bn | 5.60 Bn | 154.23 Mn | - |
| 5 | 10x Genomics | 5.89 Bn | 5.35 Bn | 106.18 Mn | - |
| 6 | MiniMed | 4.45 Bn | 4.16 Bn | 480.00 Mn | - |
| 7 | Waystar Holding | 4.41 Bn | 4.35 Bn | 216.84 Mn | 1.46 Bn |
| 8 | Doximity | 3.93 Bn | 3.18 Bn | 125.97 Mn | - |
| 9 | Privia Health | 3.10 Bn | 2.68 Bn | - | - |
| 10 | Mangoceuticals | 9.39 Mn | 9.20 Mn | 29,001.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 78,260.00 |